Australia ranked 4th in the world for the Biotechnology and Life Sciences Sector in 2014




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Australia ranked 4th in the world for the Biotechnology and Life Sciences Sector in 2014
Released on: December 05, 2014. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Australia is now a leading location for biotechnology in the global context.
  • Summary
  • Transcript
  • Participants
  • Company
Australia is now a leading location for biotechnology in the global context. There are about 100 ASX-listed life sciences companies, with a market capitalisation of more than $50 billion. The trend of increased healthcare spending and technology advancements, and the unmet medical needs for cures and treatments will continue to provide the biotech sector with growth and advancements, as well as lucrative investment opportunities. Over the last ten years, developments in biotechnology have been significant and the future holds the potential for many cures and advancements in the medical world. So what is behind Australia's success? During AusBiotech 2014 Dr AnnaLavelle, CEO, AusBiotech explains to PharmaVentures' Fintan Walton the role that AusBiotech has played.
Australia is now a leading location for biotechnology in the global context. There are about 100 ASX-listed life sciences companies, with a market capitalisation of more than $50 billion. The trend of increased healthcare spending and technology advancements, and the unmet medical needs for cures and treatments will continue to provide the biotech sector with growth and advancements, as well as lucrative investment opportunities. Over the last ten years, developments in biotechnology have been significant and the future holds the potential for many cures and advancements in the medical world. So what is behind Australia's success? During AusBiotech 2014 Dr AnnaLavelle, CEO, AusBiotech explains to PharmaVentures' Fintan Walton the role that AusBiotech has played.
Anna Lavelle
AusBiotech
AusBiotech 2016